Gregory Lambrecht
Oprichter bij Intrinsic Therapeutics, Inc.
Actieve functies van Gregory Lambrecht
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Directeur/Bestuurslid | 01-01-1999 | - |
Oprichter | 01-01-1999 | - | |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Voorzitter | - | - |
Oprichter | - | - |
Loopbaan van Gregory Lambrecht
Eerdere bekende functies van Gregory Lambrecht
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Directeur/Bestuurslid | - | 04-04-2012 |
Oprichter | 21-01-2010 | 04-04-2012 | |
PFIZER, INC. | Corporate Officer/Principal | - | - |
STRYKER CORPORATION | Verkoop & Marketing | - | - |
Opleiding van Gregory Lambrecht
Massachusetts Institute of Technology | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Founder | 3 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Finance | 2 |
Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Health Technology |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Consumer Non-Durables |
- Beurs
- Insiders
- Gregory Lambrecht
- Ervaring